S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal

Medtronic (MDT) Stock Forecast & Price Target

$79.35
-0.20 (-0.25%)
(As of 12/8/2023 ET)
Compare
Today's Range
$79.28
$79.85
50-Day Range
$69.43
$79.99
52-Week Range
$68.84
$92.02
Volume
6.24 million shs
Average Volume
6.22 million shs
Market Capitalization
$105.51 billion
P/E Ratio
25.85
Dividend Yield
3.48%
Price Target
$93.33

Medtronic Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 11 Analyst Ratings

Analysts' Consensus Price Target

$93.33
17.62% Upside
High Forecast$106.00
Average Forecast$93.33
Low Forecast$82.00
TypeCurrent Forecast
12/9/22 to 12/9/23
1 Month Ago
11/9/22 to 11/9/23
3 Months Ago
9/10/22 to 9/10/23
1 Year Ago
12/9/21 to 12/9/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
4 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
16 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$93.33$91.94$91.67$97.58
Predicted Upside17.62% Upside11.05% Upside10.80% Upside9.79% Upside
Get Medtronic Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.


MDT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medtronic Stock vs. The Competition

TypeMedtronicMedical CompaniesS&P 500
Consensus Rating Score
2.45
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside17.62% Upside735.97% Upside3,819.09% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/22/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$82.00+4.27%
11/22/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$104.00 ➝ $98.00+24.68%
8/23/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform$89.00+6.31%
8/23/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$79.00 ➝ $82.00-2.05%
8/23/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$95.00 ➝ $100.00+19.45%
8/23/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$100.00 ➝ $102.00+21.83%
8/22/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$92.00 ➝ $95.00+13.47%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$90.00+3.91%
6/30/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
6/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$106.00+22.16%
5/26/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$93.00 ➝ $90.00+7.73%
5/26/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$100.00 ➝ $99.00+18.51%
4/24/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight
2/22/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$80.00 ➝ $87.00+1.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:42 AM ET.












MDT Price Target - Frequently Asked Questions

What is Medtronic's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Medtronic stock is Hold based on the current 1 sell rating, 4 hold ratings and 6 buy ratings for MDT. The average twelve-month price prediction for Medtronic is $93.33 with a high price target of $106.00 and a low price target of $82.00. Learn more on MDT's analyst rating history.

Do Wall Street analysts like Medtronic more than its competitors?

Analysts like Medtronic less than other Medical companies. The consensus rating for Medtronic is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how MDT compares to other companies.

Does Medtronic's stock price have much upside?

According to analysts, Medtronic's stock has a predicted upside of 12.04% based on their 12-month stock forecasts.

What analysts cover Medtronic?

Medtronic has been rated by Morgan Stanley, and Royal Bank of Canada in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:MDT) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -